Scandinavian Tobacco Group (STG) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Net sales reached DKK 9.2 billion in 2024, up 5.4% year-over-year, driven by the Mac Baren acquisition and growth enablers, despite challenging market conditions and declining core cigar markets.
EBITDA before special items was DKK 2,079 million, margin 22.6%, within guidance but down year-over-year due to investments in growth and market position.
Net profit declined 20.5% to DKK 940 million, with adjusted EPS at DKK 13.7.
Returned nearly DKK 1.5 billion to shareholders via dividends and buybacks.
Advanced sustainability initiatives, including a 7.7% reduction in Scope 1 & 2 emissions (excluding Mac Baren) and SBTi validation.
Financial highlights
Net sales: DKK 9,202 million (2023: DKK 8,731 million), up 5.4% year-over-year.
EBITDA before special items: DKK 2,079 million, margin 22.6% (2023: 24.1%).
Free cash flow before acquisitions: DKK 931 million for the year.
Adjusted EPS for the quarter increased 5% to DKK 3.8; net profit declined to DKK 221 million due to higher special costs and taxes.
Special costs of DKK 148 million in Q4 related to Mac Baren integration, ERP implementation, and reorganization.
Outlook and guidance
2025 net sales expected at DKK 9.2–9.7 billion, with EBITDA margin guidance of 20%–23%.
Free cash flow projected at DKK 800 million–1.1 billion, impacted by up to DKK 300 million CapEx and DKK 200 million in special costs.
Adjusted EPS guidance: DKK 11–14.
Market for machine-rolled cigars in Europe expected to decline 3–4%; U.S. handmade cigar consumption to decline 2–3%.
Guidance ranges are broader than usual due to high macroeconomic and geopolitical uncertainty.
Latest events from Scandinavian Tobacco Group
- Organic sales fell 8.8% in Q1 2025, prompting lower guidance amid US and FX headwinds.STG
Q1 202513 Mar 2026 - 2025 results declined, but Focus2030 and strong cash flow support a stable 2026 outlook.STG
Q4 20259 Mar 2026 - Focus2030 targets growth in cigars and nicotine pouches, efficiency, and flexible shareholder returns.STG
CMD 20253 Feb 2026 - Q2 2024 saw 6.3% sales growth, margin gains, and a strategic acquisition for future expansion.STG
Q2 202423 Jan 2026 - Q3 net sales up 7.1% on Mac Baren deal; margin and organic growth declined.STG
Q3 202414 Jan 2026 - Record sales, higher dividends, and all board proposals approved amid ongoing strategic investments.STG
AGM 202529 Nov 2025 - Q2 2025 saw flat sales, margin pressure, and guidance reaffirmed despite organic decline.STG
Q2 202523 Nov 2025 - Q3 2025 organic sales rose 0.3% with margin recovery and narrowed full-year guidance.STG
Q3 202512 Nov 2025